Navigation Links
Codman Hakim Programmable Valve (CHPV)

ProductsCodman Hakim Programmable Valve (CHPV)
Company Codman
Item Codman Hakim Programmable Valve (CHPV)
Features The programmable valve allows a surgeon to non-invasively change the opening pressure between 30mm H2O and 200 mm H2O in 18 steps; negating the need for revision surgery to alter the valve pressure. The programmability of the valve may allow for the development of specialized treatment regimes. The opening pressure of the CODMAN HAKIM Programmable Valve is changed through the use of an externally applied, codified magnetic field. The spring in the ball and spring mechanism of the valve sits atop a rotating spiral cam which contains a stepper motor. Applying a specific magnetic field to the stepper motor will cause the cam to turn slightly, increasing or decreasing the tension on the spring and ball, thus changing the opening pressure of the valve. The CODMAN HAKIM programmable is available in eight basic configurations, and each of these configurations can be purchased with a unitized distal catheter or valve only.
Description Codman Hakim Programmable valve offers the ability to optimize the opening pressure of a shunt system before and after implantation. A shunted patient's condition will often change over the course of their treaent.
Info Codman
Customer Service: (800) 225-0460
Web site: http://www.codman.com

Related medicine products :

1. Codman Cervical Retractor
2. Codman Sofwire Cable System
3. Codman Anterior Cervical Plate Kit
4. Codmans Micro Osseous Dissection Curette
5. Codman-Cone Ring Curette
6. Codman Periosteal Elevators
7. Codman Hakim Programmable Valve (CHPV) Inline with Siphonguard
8. Codman Hakim Programmable Valve (CHPV) Cylindrical with Prechamber
9. Codman Hakim Programmable Valve (CHPV), Cylindrical
10. Codman Hakim Programmable Valve (CHPV) Micro
11. Codman Hakim Programmable Valve (CHPV) Micro with Rickham Reservoir
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
This instrument can be used as a spoon forceps in gynecologic surgery....
This is a single-action instrument that features a spring handle....
Medicine Products:
(Date:9/1/2015)... ... September 01, 2015 , ... Specialty Technical Publishers (STP) ... Audit Protocol Consortium (IAPC) EHS audit protocol for the European Union. Leading companies ... their EHS regulatory obligations and rapidly collect, share, archive, and export audit findings ...
(Date:8/31/2015)... ... September 01, 2015 , ... ... back pain – once required a long, arduous recovery. However, today’s minimally invasive ... pain, less blood loss and minimal muscle damage. These advantages of minimally invasive ...
(Date:8/31/2015)... ... August 31, 2015 , ... Dental clinicians from Newcastle University, ... Sciences to learn more about its integrated approach to diabetes care. , Philip ... of Cellular Medicine at Newcastle University, and Susan Bissett, National Institute for Health ...
(Date:8/31/2015)... ... August 31, 2015 , ... Wound Care Advantage, a ... second Introduction to Hyperbaric Medicine Course. The next UHMS approved 40-hour Introduction to ... Hotel in Long Beach, CA. The meeting is open for registration from physicians, ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... President, Marketing and Corporate Communications. In this capacity, Michael will provide strategic leadership ... an industry leader in consumer-focused programs that have contributed to the company’s rapid ...
Breaking Medicine News(10 mins):Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 2Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 3Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 4Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 2Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 3Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 4Health News:Western Diabetes Institute Collaborates with UK team 2Health News:Western Diabetes Institute Collaborates with UK team 3Health News:Western Diabetes Institute Collaborates with UK team 4Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 4Health News:CareSource Names Vice President, Marketing and Corporate Communications 2
... of adenocarcinoma of the esophagus (or gullet) has been on ... treatment are improving the outlook for patients. In the current ... Int 2011; 108[18]: 313𔃇), Angelika Behrens and her working ... main cause of this cancer is reflux of gastric acid ...
... HILL, N.C. By the age of 20, most people have ... it was assumed that skeletal enlargement elsewhere in the body also ... at the University of North Carolina at Chapel Hill has found ... ("hipbones") does continue to widen as people advance in age from ...
... Phase III study presented today at the EULAR 2011 Annual ... who had previously not responded to treatment with DMARDs, achieved ... with the novel oral Janus kinase inhibitor tofacitinib at 10mg ... improvements were also observed in the 5 mg BID dose. ...
... tend to have lower earnings and labor force participation ... disability benefits, a new study finds. Rejected applicants ... accepted applicants, according to the research led by economist ... average, the study found, those rejected for benefits made ...
... , TUESDAY, May 24 (HealthDay News) -- Drug company marketing ... students, ethical judgment, researchers warn. A team led by ... in Boston analyzed published studies that included a total of ... The investigators found that most of the students had some ...
... Clinical trials for a new bladder cancer therapy show ... the breakthrough using the drug Urocidin follows thirty years ... am optimistic about the results of the trial," says ... at Queen,s University and director of the Queen,s University ...
Cached Medicine News:Health News:Pelvic widening continues throughout a person's lifetime, UNC study 2Health News:US study shows that tofacitinib is an efficacious treatment for active RA 2Health News:Study finds much different work histories for disability rejects, beneficiaries 2Health News:Drug Marketing Often Targets Med Students: Analysis 2Health News:New made-in-Canada therapy for bladder cancer shows promising results 2
(Date:8/31/2015)... , Aug. 31, 2015  Soligenix, Inc. ... biopharmaceutical company developing products that address unmet medical ... biodefense, announced today it has completed enrollment of ... Review Committee (DRC) earlier this year, into the ... a first-in-class innate defense regulator (IDR) and is ...
(Date:8/31/2015)... Aug. 31, 2015  QT Vascular Ltd., together with its ... with its subsidiaries, the "Group"), a global company ... advanced therapeutic solutions for the minimally invasive treatment ... of the below-the-knee ("BTK") cohort of patients in ... presented on August 15, 2015 at the 5th ...
(Date:8/30/2015)... y LONDRES, August 30, 2015 ... holística de l cuidado al paciente ... trayecto   Royal Philips  ... europeo de IntelliSpace Cardiovascular , un sistema web ... herramientas para acceder, analizar y compartir imágenes cardiovasculares e ...
Breaking Medicine Technology:Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 2Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 3Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 4Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 5Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 6Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 2Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 3Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 4Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3